Literature DB >> 33964330

The emerging roles of dual-specificity phosphatases and their specific characteristics in human cancer.

Ping-Ping Gao1, Xiao-Wei Qi1, Na Sun1, Yuan-Yuan Sun2, Ye Zhang1, Xuan-Ni Tan1, Jun Ding3, Fei Han4, Yi Zhang5.   

Abstract

Reversible phosphorylation of proteins, controlled by kinases and phosphatases, is involved in various cellular processes. Dual-specificity phosphatases (DUSPs) can dephosphorylate phosphorylated serine, threonine and tyrosine residues. This family consists of 61 members, 44 of which have been identified in human, and these 44 members are classified into six subgroups, the phosphatase and tensin homolog (PTEN) protein phosphatases (PTENs), mitogen-activated protein kinase phosphatases (MKPs), atypical DUSPs, cell division cycle 14 (CDC14) phosphatases (CDC14s), slingshot protein phosphatases (SSHs), and phosphatases of the regenerating liver (PRLs). Growing evidence has revealed dysregulation of DUSPs as one of the common phenomenons and highlighted their key roles in human cancers. Furthermore, their differential expression may be a potential biomarker for tumor prognosis. Despite this, there are still many unstudied members of DUSPs need to further explore their precise roles and mechanism in cancers. Most importantly, the systematic review is very limited on the functional/mechanistic characteristics and clinical application of DUSPs at present. In this review, the structures, functions and underlying mechanisms of DUSPs are systematically reviewed, and the molecular and functional characteristics of DUSPs in different tumor types according to the current researches are summarized. In addition, the potential roles of the unstudied members and the possible different mechanisms of DUSPs in cancer are discussed and classified based on homology alignment and structural domain analyses. Moreover, the specific characteristics of their expression and prognosis are further determined in more than 30 types of human cancers by using the online databases. Finally, their potential application in precise diagnosis, prognosis and treatment of different types of cancers, and the main possible problems for the clinical application at present are prospected.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Clinical application; Dual-specificity phosphatases; Function; Structure

Year:  2021        PMID: 33964330     DOI: 10.1016/j.bbcan.2021.188562

Source DB:  PubMed          Journal:  Biochim Biophys Acta Rev Cancer        ISSN: 0304-419X            Impact factor:   10.680


  4 in total

1.  Role of dual specificity phosphatases (DUSPs) in melanoma cellular plasticity and drug resistance.

Authors:  Mithalesh K Singh; Sarah Altameemi; Marcos Lares; Michael A Newton; Vijayasaradhi Setaluri
Journal:  Sci Rep       Date:  2022-08-23       Impact factor: 4.996

2.  Genomic Assessment of Cancer Susceptibility in the Threatened Catalina Island Fox (Urocyon littoralis catalinae).

Authors:  Sarah A Hendricks; Julie L King; Calvin L Duncan; Winston Vickers; Paul A Hohenlohe; Brian W Davis
Journal:  Genes (Basel)       Date:  2022-08-22       Impact factor: 4.141

Review 3.  Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolism.

Authors:  Pegah Abdollahi; Esten N Vandsemb; Magne Børset
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2022-01-01       Impact factor: 4.294

Review 4.  Deciphering the Role of Protein Phosphatases in Apicomplexa: The Future of Innovative Therapeutics?

Authors:  Aline Fréville; Bénédicte Gnangnon; Asma S Khelifa; Mathieu Gissot; Jamal Khalife; Christine Pierrot
Journal:  Microorganisms       Date:  2022-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.